BlackRock Inc. - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAD3. A total of 11 filers reported holding PTC THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,446,313
-15.6%
1,825,000
+9.0%
0.00%
Q2 2023$1,712,688
-17.1%
1,675,000
-8.2%
0.00%
Q1 2023$2,065,900
-29.4%
1,825,000
-37.6%
0.00%
Q4 2022$2,927,925
-0.0%
2,925,000
+17.0%
0.00%
Q3 2022$2,929,000
-4.0%
2,500,000
-14.5%
0.00%
Q2 2022$3,052,0002,925,0000.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
STEELHEAD PARTNERS LLC 51,240,000$50,481,1363.68%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 32,000,000$31,357,4400.65%
WOLVERINE ASSET MANAGEMENT LLC 45,749,000$45,087,7410.47%
CSS LLC/IL 2,945,000$2,881,6120.16%
LINDEN ADVISORS LP 12,800,000$12,795,0600.13%
FRANKLIN RESOURCES INC 63,000,000$63,378,0000.03%
Citadel Advisors 75,901,000$74,474,0610.02%
KORNITZER CAPITAL MANAGEMENT INC /KS 600,000$600,6000.01%
CREDIT SUISSE AG/ 240,000$234,9050.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of PTC THERAPEUTICS INC shareholders